Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharmacol ; 324(1): 129-33, 1997 Apr 11.
Article in English | MEDLINE | ID: mdl-9137923

ABSTRACT

Phorbol 12-myristate 13-acetate (PMA), N,N'-hexamethylenebisacetamide (HMBA) and retinoic acid induce cell differentiation in U-937 promonocytic cells. This report examines the effects of these agents on DNA topoisomerase I activity. A decrease in enzyme activity could be detected as early as 30 min after treatment with all three differentiating compounds and lasted at least 48 h. No alteration in the levels of DNA topoisomerase I transcript or protein was observed during these treatments. The results might be explained by post-translational events that render DNA topoisomerase type I less active.


Subject(s)
Acetamides/toxicity , Antineoplastic Agents/toxicity , Carcinogens/toxicity , DNA Topoisomerases, Type I/drug effects , Tetradecanoylphorbol Acetate/toxicity , Tretinoin/toxicity , Blotting, Northern , Blotting, Western , Cell Transformation, Neoplastic/drug effects , DNA Topoisomerases, Type I/metabolism , Electrophoresis, Polyacrylamide Gel , Humans , Leukemia, Myeloid/pathology , Transcription, Genetic/drug effects , Transcription, Genetic/genetics , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...